------------------------------
OMB APPROVAL
------------------------------
OMB NUMBER 3235-0287
EXPIRES: DECEMBER 31, 2001
ESTIMATED AVERAGE BURDEN
HOURS PER RESPONSE ....... 0.5
------------------------------
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
[ ] CHECK THIS BOX IF NO LONGER SUBJECT TO SECTION 16. FORM 4 OR FORM 5
OBLIGATIONS MAY CONTINUE. SEE INSTRUCTION 1(B).
(Print or Type Response)
================================================================================
1. Name and Address of Reporting Person(*)
Mehra Sanjeev K.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Goldman, Sachs & Co., 85 Broad Street
--------------------------------------------------------------------------------
(Street)
New York NY 10004
--------------------------------------------------------------------------------
(City) (State) (Zip)
================================================================================
2. Issuer Name and Ticker or Trading Symbol
ProMedCo Management Company (NASDAQ:PMCO)
================================================================================
3. IRS or Social Security Number of Reporting Person (Voluntary)
================================================================================
4. Statement for Month/Year
July/2000
================================================================================
5. If Amendment, Date of Original (Month/Year)
================================================================================
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
[ X ] Director [ ] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
--------------------------------------------------------------------
================================================================================
7. Individual or Joint/Group Filing
(Check Applicable Line)
[ X ] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
================================================================================
TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF,
OR BENEFICIALLY OWNED
================================================================================
<TABLE>
<CAPTION>
6.
4. 5. Owner-
Securities Acquired (A) or Amount of ship
3. Disposed of (D) Securities Form: 7.
Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of
2. Code ------------------------------- Owned at End (D) or Indirect
1. Transaction (Instr. 8) (A) of Month Indirect Beneficial
Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) (mm/dd/yy) Code V (D) and 4) (Instr.4) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION
CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS
A CURRENTLY VALID OMB NUMBER.
FORM 4 (continued)
TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
(E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
================================================================================
<TABLE>
<CAPTION>
9. 10.
Number Owner-
of ship
2. Deriv- Form of
Conver- 5. 7. ative Deriv- 11.
sion Number of Title and Amount Secur- ative Nature
or Derivative 6. of Underlying 8. ities Secur- of
Exer- 4. Securities Date Securities Price Bene- ity: In-
cise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct
Price Trans- action or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene-
1. of action Code of(D) (Month/Day/Year) Amount ative at End In- ficial
Title of Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner-
Derivative ative (Month/ 8) 4 and 5) Date Expira- Number ity Month (I) ship
Security Secur- Day/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
(Instr. 3) ity Year) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Series A $2.50 7/13/00 S 77,273 Immed. 6/12/07 Common 3,090,920 (2) 347,727 I(1) (1)(3)
Convertible (2) Stock
Preferred
Stock
-----------------------------------------------------------------------------------------------------------------------------------
Series B $4.00 7/13/00 S 22,727 Immed. 6/12/07 Common 568,175 (2) 102,273 I(1) (1)(3)
Convertible (2) Stock
Preferred
Stock
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Explanation of Responses: (SEE ATTACHED PAGES)
/s/ Roger S. Begelman August 10, 2000
--------------------------------------------- -----------------------
(**)Signature of Reporting Person Date
Sanjeev K. Mehra by Attorney-in-fact
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.
POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION
CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS
A CURRENTLY VALID OMB NUMBER.
<PAGE>
Form 4
Explanation of Responses
Item 1: Sanjeev K. Mehra
c/o Goldman, Sachs & Co.
85 Broad Street
New York, NY 10004
Item 2: ProMedCo Management Company (NASDAQ:PMCO)
Item 4: July 2000
------------------------------------------------------------------------
(1) The Reporting Person is a managing director of Goldman, Sachs & Co.
("Goldman Sachs"). Goldman Sachs is an indirect wholly-owned
subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The
Reporting Person disclaims beneficial ownership of the securities
reported herein except to the extent of his pecuniary interest
therein, if any.
(2) Pursuant to the Stock Purchase Agreement, dated as of July 13, 2000,
by and among MTS Investors E, L.P., a Delaware limited partnership
("MTS"), and certain investment partnerships of which affiliates of
Goldman Sachs and GS Group are the general partner or managing
partner (the "Limited Partnerships"), the Limited Partnerships sold
to MTS (i) an aggregate of 77,273 shares of Series A Convertible
Preferred Stock, par value $0.01 per share ("Series A Preferred
Stock") of ProMedCo Management Company (the "Company") for
$7,495,481 (or $97.00 per share of Series A Preferred Stock) and
(ii) an aggregate of 22,727 shares of the Company's Series B
Convertible Preferred Stock ("Series B Preferred Stock") for
$2,204,519 (or $97.00 per share of Series B Preferred Stock). Such
shares of Series A Preferred Stock and Series B Preferred Stock that
were sold on July 13, 2000 had been acquired for $97.00 per share on
June 12, 2000 in certain transactions that had been approved by the
Company's board of directors and by the holders of a majority of the
shares of Common Stock at a special meeting of the Company's
stockholders held on June 12, 2000, and, to the extent such purchase
transactions were reportable by reason of a director relationship
with the issuer, that were exempt transactions with the issuer.
(3) Goldman Sachs and GS Group may be deemed to own beneficially and
indirectly in the aggregate 16,465,905 shares of the Company's
Common Stock, par value $0.01 per share ("Common Stock"), as a
result of the deemed beneficial ownership of 347,727 shares of
Series A Preferred Stock and 102,273 shares of Series B Preferred
Stock by the Limited Partnerships.
